To sum up, the data verify that c-FOS contributes to the regulation of tumor-associated neutrophils, which implies that c-FOS is likely to function as the therapeutic target for lung metastasis in breast cancer (Fig. 9). This evidence concerns the gene FOS and breast carcinoma.